09/24/2025
The ALFC 2025 agenda is live! Our parent company, DCN Dx, hosts this annual event. This year’s program brings together leading experts and innovators to share insights on funding, commercialization, regulatory pathways, and breakthrough technologies.
With keynotes, technical talks, poster presentations, the New Product Showcase, a lively Exhibit Room, and networking opportunities, the agenda is packed with content designed to move the field forward. Agenda highlights include:
From Battlefield to Benchside: How Strategic AI is Reshaping Science Ops—Jeremy Elser, Ph.D. (Head of Science Operations, Palantir Technologies)
Executive's Corner: Running Diagnostics Companies in the Age of Complexity—Moderated by James Zanewicz, JD, LLM, RTTP (CEO, San Diego Connect and EVP, Medicine and Research, Makyr); and joined by panelists Charlie Mamrak (CEO, DCN Dx), Thomas Plotts (CFO / COO, Gravidas Diagnostics, Inc.), Tony Serafini-Lamanna (President, Diagnostics, Meridian Bioscience), and Tomás Toribio (Managing Director, OPERON, S.A.)
Innovation Award Pitches—Finalists present in a live “Shark Tank”-style session to judges Owen Davis (Managing Partner, Martis Capital); Donna Hochberg, Ph.D. (Partner & Managing Director, Head of Dx, PM & LST & Services, Health Advances); Brian Weinstein (Managing Director, Medical Technology, William Blair); and Pat Vaughan, Ph.D. (COO, DCN Dx); hosted by Mitzi Rettinger (Chief Revenue Officer, DCN Dx). The $10,000 prize will be announced at the Oct. 15 Closing Reception and Awards Ceremony.
Raising Right: Why Diagnostics Startups Fail to Fund—Giles Hamilton (Board Member, and Investor)
See what’s in store and start planning your conference experience today. Link to the full agenda is in the comments.
